Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neural Transmission - Parkinsons Disease and Dementia Section

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02253436PMID 7710669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotransmitter markers in the cerebrospinal fluid of normal subjects effects of aging and other confounding factors

  2005cited by this paper
• PET studies on the early and differential diagnosis of Parkinson's disease

  1993cited by this paper
• Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes

  1993cited by this paper
• Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid

  1993cited by this paper
• Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.

  1993cited by this paper
• Markers of dopamine metabolism in Parkinson's disease

  1992cited by this paper
• Criteria for diagnosing Parkinson's disease

  1992cited by this paper
• Cerebrospinal Fluid in Diseases of the Nervous System

  1992cited by this paper
• Brachial plexus palsy associated with spasmodic torticollis in a patient with tomaculous neuropathy

  1992cited by this paper
• Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging.

  1992cited by this paper
• PET: Motor function and dysfunction

  1992cited by this paper
• A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.

  1991cited by this paper
• Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study

  1991cited by this paper
• Significant correlation between cerebrospinal fluid and brain levels of norepinephrine, serotonin and acetylcholine in anesthetized rats.

  1991cited by this paper
• Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.

  1990cited by this paper
• The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

  1990cited by this paper
• Toward a definition of Parkinson's disease

  1989cited by this paper
• Central depletion of dopamine in rats by 1-methyl-4-phenylpyridine.

  1989cited by this paper
• Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.

  1989cited by this paper
• Parkinsonism‐plus syndromes

  1989cited by this paper
• Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.

  1987cited by this paper
• Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.

  1987cited by this paper
• Vasopressin levels in the cerebrospinal fluid in rats of different age and sex.

  1986cited by this paper
• MPTP: current concepts and controversies.

  1986cited by this paper
• Application of the dual-cell coulometric detector: a method for assaying monoamines and their metabolites.

  1985cited by this paper
• Assessment of Parkinson's Disease

  1984cited by this paper
• Homovanillic Acid in the Cerebrospinal Fluid of Parkinsonian Patients

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders

  1976cited by this paper
• Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.

  1974cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Central monoamine metabolism in Parkinson's disease.

  1972cited by this paper
• Neurochemistry of Parkinsonism

  1972cited by this paper
• 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

  1967cited by this paper
• Parkinsonism

  1967cited by this paper
• The prevention of acute gastric ulcer in the rat by alpha-methyldopa.

  1967cited by this paper

• Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [18F]FP-(+)-DTBZ

  2018cites this paper
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson’s disease and controls

  2013cites this paper
• Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease*S

  2009cites this paper
• Inter‐rater reliability of the International Cooperative Ataxia Rating Scale (ICARS)

  2004cites this paper
• Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients

  2004cites this paper
• Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

  2004cites this paper
• Phenotypic characterization of DYT13 primary torsion dystonia

  2004cites this paper
• Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus

  2004cites this paper
• Amino Acids and Biogenic Amines in Cerebrospinal Fluid of Patients with Parkinson's Disease

  2003cites this paper
• Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

  2001cites this paper
• Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.

  1997cites this paper
• CSF somatostatin increase in patients with early parkinsonian syndrome

  1995cites this paper
• Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.

  1995cites this paper
• Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.

  1995cites this paper